In a world of social media overwhelm and paradoxical real-life isolation and loneliness, surviving adolescence today is hard enough, but for teens living with social anxiety disorder, it can feel even ...
In a groundbreaking stride toward transforming the landscape of anxiety treatment, biopharmaceutical company VistaGen has unveiled promising top-line results from its Phase 3 PALISADE-2 trial. This ...
Please provide your email address to receive an email when new articles are posted on . Participants in the phase 3 trial were significantly less anxious during a public speaking challenge after ...
Feeling anxious, fearful, or avoidant about situations that might involve the scrutiny of others can be a part of social anxiety and social phobia. The scope and intensity of symptoms and their ...
Vistagen Therapeutics Inc. (($VTGN)) announced an update on their ongoing clinical study. Vistagen Therapeutics Inc. is conducting a Phase 2 ...
1don MSN
Vistagen targets NDA submission for fasedienol in mid-2026 as PALISADE-3 study nears data readout
Get the latest on Vistagen Therapeutics' Q2 2026 earnings, PALISADE-3 trial milestones, and upcoming fasedienol data.
What if everything we’re doing to help anxious kids is actually making them worse? A new approach challenges it all±in just ...
Some anxiety is part of the cost of admission to humanity. Because its distinguishing raison d’etre is the anticipation of bad outcomes, it can be a helpful stimulus to preparation or rehearsal before ...
Just an hour of socializing per day helped mice fight tumors. Now scientists have traced the brain circuitry that turns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results